Core Laboratories (NYSE: CLB) reported Q2 EPS of $0.59, in-line with the analyst estimate of $0.59. Revenue for the quarter came in at $175.5 million versus the consensus estimate of $174.48 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.